Amgen becomes a strong cancer player

Article Abstract:

Amgen of Thousand Oaks, California, in a move aimed at reinforcing presence in the oncology field, signed a deal to purchase Abgenix of Fremont, California, to be finalized by the first quarter of 2006. The December 2006 agreement was driven by successful clinical results of Abgenix's fully human antibody panitumumab against cancer and this deal could give Amgen a broader reach into the medicinal field.

United States, California, Amgen Inc., AMGN, Abgenix Inc., ABGX

---

Merck moves into biotech

Article Abstract:

Merck, the oldest and stodgiest pharmaceutical companies in May 2006 announced its plans to purchase two protein manufacturing firm that include GlycoFi for $400 million and Abmaxis for $80 million as most of the traditional pharmaceutical companies are acquiring biologics outlets. The company has signed at least 16 deals with various companies since 200 and has a long-standing vaccine program.

Capacity, Biotechnology industry, Biotechnology industries, Merck & Company Inc.

---

ZymoGenetics' moves recall young Genentech

Article Abstract:

The Seattle-based company, ZymoGenetics has signed an agreement with Bayer Healthcare to share the marketing rights to Zymo's recombinant thrombin.

Marketing procedures, Government regulation, Contracts & orders received, Management dynamics, Contracts & orders let, Management, Germany, Marketing, Contracts, Biological products industry, Contract agreement, Licensing, certification and accreditation, Genentech Inc., Company marketing practices, Company business management, Thrombin, ZymoGenetics Inc., DNA, Bayer HealthCare AG

Similar abstracts:

• Abstracts: The promise of cancer vaccines. Knocking the SOCS1 off dendritic cells. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
• Abstracts: The business case. Inventory check
• Abstracts: An end to doorstops: segmentation studies should do more than sit on your floor. The right questions
• Abstracts: S corporation rules liberalized by the American Jobs Creation Act of 2004. New section 409A makes deferred compensation a whole new ball game

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.